Pantoprazole Teva Teva Conseil (Pantoprazole Sodium)

Pantoprazole Teva Teva Conseil is a proton pump inhibitor that acts on the gastric acid secretion pathway.

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining.
• Erosive esophagitis: accelerates mucosal healing and reduces further erosion.
• Peptic ulcer disease: supports ulcer healing and prevents recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid production, leading to a sustained increase in gastric pH and reduction of gastric acidity.

Adverse reactions to pantoprazole are generally mild to moderate and vary in frequency.

Common Side Effects

• Headache: mild, transient headache reported by some patients.
• Diarrhea: loose stools occurring during early treatment.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach area.
• Flatulence: increased intestinal gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Clostridioides difficile infection: severe diarrhea with abdominal pain.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Liver enzyme elevation: increased ALT/AST indicating hepatic stress.
• Fracture risk: potential decrease in bone mineral density with long‑term use.

Before initiating therapy, consider patient‑specific factors and monitor appropriately.

• Renal impairment: dose adjustment may be required in severe kidney disease.
• Hepatic impairment: use with caution in patients with liver dysfunction.
• Elderly patients: monitor for increased sensitivity to side effects.
• Concomitant use of drugs requiring gastric acidity: assess potential reduced efficacy.
• Pregnancy and lactation: evaluate risk‑benefit ratio before prescribing.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole may affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): reduced absorption due to increased gastric pH.
• HIV protease inhibitors (atazanavir, nelfinavir): markedly decreased plasma concentrations.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR; monitor coagulation parameters.
• Methotrexate: reduced renal clearance may raise serum levels.
• Digoxin: slight increase in serum concentration; observe for toxicity signs.
• Clopidogrel: potential reduction in antiplatelet effect; consider alternative therapy.